Apr 21, 2026
Boston Scientific (BSX) Plunges to 52-Week Low as Wall Street Adjusts Forecasts Pre-Earnings
Boston Scientific (BSX) drops 36% YTD to $60.54 as analysts lower targets ahead of Q1 earnings. Despite cuts, firms maintain Buy ratings with upside potential.
The post Boston Scientific (BSX) Plunges to 52-Week Low as Wall Street Adjusts Forecasts Pre-Earnings appeared first on Blockonomi.
Source: Blockonomi →Related News
- 31 minutes ago
BlackRock in Talks to Invest Up to $10 Billion in SpaceX IPO Ahead of June Listi...
- 8 hours ago
7 Stock Sectors Poised to Dominate the Next Half-Decade: AI, Defense, and Beyond
- 8 hours ago
Nvidia (NVDA) Stock Expands CoreWeave (CRWV) Holdings by 95% in Strategic AI Pla...
- 8 hours ago
Wall Street’s Elite Quietly Accumulated These 5 Stocks in Q1 2026 – Microsoft (M...
- 8 hours ago
Macy’s (M) Stock Surges 6% as Berkshire Hathaway Takes $55M Position